LT - Metil-{4,6-diamino-2-[1-(2-fluorbenzil)-1H-pirazol[3,4-b]piridin-3-il]pirimidin-5-il}metilkarbamato, skirto naudoti kaip farmaciškai veiksmingo ingrediento, gamybos būdas
EN - Process for the preparation of methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate for use as pharmaceutically active ingredient
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
C07D 471/04 |
(2006.01) |
European patent
(11) |
Number of the document |
2733142 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
14154762.0 |
|
Date of filing the European patent application |
2010-11-22 |
(97) |
Date of publication of the European application |
2014-05-21 |
(45) |
Date of publication and mention of the grant of the patent |
2018-08-01
|
(46) |
Date of publication of the claims translation |
2018-10-10
|
Priority applications
(30) |
Number |
Date |
Country code |
|
09177371 |
2009-11-27
|
EP |
Inventors
(72) |
Mais, Franz-Josef, DE
Rehse, Joachim, DE
Jöntgen, Winfried, DE
Siegel, Konrad, DE
|
Grantee
(73) |
Adverio Pharma GmbH,
Kaiser-Wilhelm-Allee 1, 51373 Leverkusen,
DE
|
Attorney or representative
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Title
(54) |
Metil-{4,6-diamino-2-[1-(2-fluorbenzil)-1H-pirazol[3,4-b]piridin-3-il]pirimidin-5-il}metilkarbamato, skirto naudoti kaip farmaciškai veiksmingo ingrediento, gamybos būdas |
|
Process for the preparation of methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate for use as pharmaceutically active ingredient |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2024-10-21 |
15 |
289.00
EUR
|
Next renewal fee
|
2025-11-22 |